Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Fröhlich Eleonore |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Rinner, B; Fröhlich, E; Villa, M Sample preparation from tissues and advanced cell culture models
Alpenflow 2024; MAY, 23-25, 2024; Bad Ischl, AUSTRIA. 2024. [Oral Communication]

 

T. Baniček, T; Hoffmann, M; V. Todaro, V; Cavecchi, A; Fröhlich, E; Salar-Behzadi, S Characterization of Lyotropic Liquid Crystalline Phases in Lipid Nanoparticles
18th Annual PSSRC Symposium; AUG 27-29, 2024; Dortmund, GERMANY. 2024. [Poster]

 

Zeiringer, S; Hartl, S; Kolesnik, T; Leitinger, G; Fröhlich, E; Mussbacher, M; Roblegg, E In-vitro differentiation and characterization of monocytes to evaluate the influence of nanocarriers on antigen presenting cells
14th ASEM Workshop 2024 on Advanced Electron Microscopy; APR 4-5, 2024; Graz, AUSTRIA. 2024. [Oral Communication]

 

Fröhlich, E Replacement strategies for animal studies in inhalation testing
RESCON Europe Summit 2023; 19.21, 2023; Porto, PORTUGAL. 2023. [Oral Communication]

 

Glader, C; Tetyczka, C; Jeitler, R; Fröhlich, E; Mußbacher, M; Roblegg, E Establishment of a lipid nano-platform to enable the local application of complex drugs to the oral mucosa
4th European Conference on Pharmaceutics; MAR, 20 - 21, 2023; Marseille, FRANCE. 2023. [Poster]

 

Michlewska, S; Absenger-Novak. M; Fröhlich, E; Robaszkiewicz, A Quantification of poly(aneu)ploid cells with confocal imaging
2nd CA17140 STSM Virtual Conference; FEB 23, 2023; Lodz, POLAND. 2023. [Oral Communication]

 

Nizard, H; Fröhlich, E; Kykal, C; Klinkenberg, S; Hecker, D; Gloess, D Operator Risk Assessment during Dismounting and Cleaning of a Gas Aggregation Nanocomposite Deposition Source
Nanoworkshop 2023; SEP 12-15, 2023; Plön Castle, GERMANY. 2023. [Oral Communication]

 

Scheipl, S; Barnard, M; Lohberger, B; Liegl-Atzwanger, B; Rinner, B; Fröhlich, E Kombinations-Screening als translationaler Zugang zu einer verbesserten medikamentösen Therapie von Chordomen.
Abstract book des 2. Österreichischen Kongresses für Orthopädie und Traumatologie. 2023; -2. Österreichischer Kongress für Orthopädie und Traumatologie; MAI 4-6, 2023; Vienna, AUSTRIA. [Oral Communication]

 

Vidakovic, I; Horn, C; Quehenberger, J; Fiedler, D; Khinast, J; Tetyczka, C; Absenger- Novak, M; Fröhlich, E; Leitinger, G; Kornmueller, K; Prassl, R Archaeasomes: from continuous manufacturing to powdered formulation.
BioNanoMed 2023. 11th International Congress - Nanotechnology in Biology & Medicine; APR 12-14, 2023; Graz, AUSTRIA;. 2023. [Poster]

 

Selmani, A; Vidakovic, I; Tetyzka, C; Leitinger, G; Fröhlich, E; Roblegg, E; Bernkop-Schnürch, A; Prassl, R Thiolated liposomes as mucoadhesive oral delivery system
NANO2CLINICS - Cancer Nanomedicine from Bench to Bedside; OCT 24-27, 2022; Rome, Italy. 2022. [Oral Communication]

 

Bernecker, C; Leita, R; Kolesnik, T; Lampl, A; Ciubotaru, CD; Fröhlich, E; Schlenke, P; Cojoc, D; Dorn, I Comprehensive analyses of the link between shape, structure and function in ex vivo generated and native red blood cells
ISEH 50th annual scientific meeting; AUG 26-29, 2021; New York, USA. 2021. [Onlinepräsentation]
FullText

 

De Leon, G; Fröhlich, E; Salar-Behzadi, S Comparison between two Bitterness Predictors using Extended Connectivity Fingerprints and selected Physicochemical Descriptors.
European Biotechnology Congress; SEP 23-25, 2021; Sofia, Bulgaria. 2021. [Oral Communication]

 

De León, G; Fröhlich, E; Salar-Behzadi, S An ensemble model for bitterness prediction: a practical tool for virtual screening of bitterants.
AIChE Annual Meeting ; NOV 15-17; Boston, USA. 2021. [Oral Communication]

 

Fröhlich, E in vitro/In silico testing FOR the assessment of inhaled particles.
European Society of Medicine Congress; NOV, 11-13, 2021; Vienna, Austria. 2021. [Oral Communication]

 

Fröhlich, E Assessment of repeated pulmonary exposure to nanoparticles by in -vitro models.
Second Conference on Current Hygienic Aspects of Nanotoxicology; OCT, 20-21, 2021; Ekaterinburg, Russia. 2021. [Oral Communication]

 

Fröhlich, E; Meindl, C; Öhlinger, K; Absenger-Novak Cellular long-term culture models for the respiratory tract.
Workshop Active Organotypic Models for Nanoparticle Toxicological Screening; JUN, 22, 2021; Sulzbach, Germany. 2021. [Oral Communication]

 

Fröhlich, E; Meindl, C; Öhlinger, K; Kolesnik, T; Absenger-Novak, M Evaluation of aerosols by physiologically relevant in vitro systems
3R Days; NOV, 10-12, 2021; Graz, Austria. 2021. [Oral Communication]

 

Fröhlich, E; Meindl, C; Öhlinger, K; Kolesnik, T; Absenger-Novak, M Assessment of biological effects caused by inhaled nanoparticles.
3rd International Conference on Graphene and Novel Nanomaterials; AUG, 16-19, 2021; Macau, China. 2021. [Oral Communication]

 

Radivojev, S; Beretta, M; Reinisch, V; Rehbein, V; Pinto, JT; Fröhlich, E; Paudel, A Investigation of process parameters and carrier type impact on the deposition patterns of ICS/LABA DPI combination product
Drug Delivery to the Lungs 2021; DEC, 8-10, 2021; Edinburgh, United Kingdom. 2021. [Poster]

 

Radivojev, S; Kargl, L; Meindl, C; Pinto, JT; A. Paudel, A; Fröhlich, E The influence of mucus on the permeability of inhalable APIs.
European Aerosol Conference; AUG 30-SEP 3, 2021; Bristol, United Kingdom. 2021. [Poster]

 

Radivojev, S; Kargl, L; Meindl, C; Pinto, JT; Paudel, A; Fröhlich, E The influence of mucus on the permeability of inhalable APIs
Pharmaceutical Solid State Research Cluster Meeting virtual; OCT 13, 2021; virtual. 2021. [Oral Communication]

 

Radivojev, S; Luschin-Ebengreuth, G; Pinto, JT; Paudel, A; Frohlich, E THE RELEVANCE OF SIMULATED LUNG FLUID COMPOSITION ON THE DRUG SOLUBILITY AND PREDICTED IN-VIVO PERFORMANCE OF INHALED DRUG DELIVERY
J AEROSOL MED PULM D. 2021; 34(3):A11-A11. [Poster]
Web of Science

 

Radivojev, S; Pinto, JT; Laggner, P; Fröhlich, E; Paudel, A The impact of interaction between inhaled drugs and lung surfactant on in-vitro solubility and predicted in-vivo performance.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; FEB 8-11, 2021; Vienna, Austria. 2021. [Poster]

 

De León, G; Fröhlich; Salar-Behzadi, S Virtual screening for hTAS2Rs ligands: a predictive model using Adaboost and ECFP.
European Biotechnology Congress 2020; SEP 24-26, 2020; Prague, Czechia. 2020. [Poster]

 

Radivojev, S; Luschin-Ebengreuth, G; Pinto, JT; Paudel, A; Fröhlich, E The relevance of simulated lung fluid composition on the drug solubility and predicted in-vivo performance of inhaled drug delivery.
2020 Virtual AIChE Annual Meeting; NOV 16-20, 2020; virtual. 2020. [Poster]

 

Radivojev, S; Luschin-Ebengreuth, G; Pinto, JT; Paudel, A; Fröhlich, E The relevance of simulated lung fluid composition on the drug solubility and predicted in-vivo performance.
Pharmaceutical Solid-State Research Cluster; JUN, 23, 2020; virtual. 2020. [Oral Communication]

 

Radivojev, S; Luschin-Ebengreuth, G; Pinto, JT; Paudel, A; Fröhlich, E The relevance of simulated lung fluid composition on the drug solubility and predicted in-vivo performance of inhaled drug delivery.
Drug Delivery to the Lungs Conference; DEC, 9-11, 2020; virtual. 2020. [Oral Communication]

 

Radivojev, S; Pinto, JT; Laggner, P; Fröhlich, E; Paudel, A STRUCTURAL INVESTIGATION INTO THE PHYSICAL INTERACTIONS OF ITRACONAZOLE WITH DPPC.
J AEROSOL MED PULM D. 2020; 33(2):A6-A7.-Drug Delivery to the Lungs; DEC 11-13; Edinburgh, Scotland. [Poster]
Web of Science

 

Fröhlich, E Developments in cell-based image analysis: High content screening
Alpenflow 2019; Dec 7-9, 2019; Bad Ischl, Austria. 2019. [Oral Communication]

 

Öhlinger, K; Absenger-Novak, M; Fröhlich, E High content screening as useful tool for in vitro drug screening
3R Tage in Graz; FEB, 27-28; Graz, AUSTRIA. 2019. [Poster]

 

Pinto, JT; Radivojev, S; Frohlich, E; Paudel, A INSIGHTS INTO DPI SENSITIVITY TO HUMIDITY AND ITS CORRELATION TO FORMULATION PHYSICOCHEMICAL CHARACTERISTICS: A TEMPORAL STUDY USING TWO COMMERCIAL BUDESONIDE PRODUCTS
J AEROSOL MED PULM D. 2019; 32(2):A2-A2. [Poster]
Web of Science

 

Radivojev, S; Pinto, JT; Frohlich, E; Paudel, A INSIGHTS INTO HUMIDITY-INDUCED CHANGES ON THE IN-VITRO PULMONARY DEPOSITION AND THE PREDICTED PLASMA LEVELS OF BUDESONIDE FROM COMMERCIAL DPIS: A PHARMACOKINETIC MODEL ASSISTED RISK ASSESSMENT APPROACH
J AEROSOL MED PULM D. 2019; 32(2):A4-A4. [Poster]
Web of Science

 

Radivojev, S; Pinto, JT; Laggner, P; Fröhlich, E; Paudel, A Structural investigation into the physical interactions of itraconazole with DPPC
Pharmaceutical Solid State Research Cluster Meeting 2019; SEPT, 12-14; Düsseldorf, GERMANY. 2019. [Oral Communication]

 

Radivojev, S; Pinto, JT; P Laggner, P; E Fröhlich, E; Paudel, A Structural investigation into the physical interactions of itraconazole with DPPC
Drug Delivery to the Lungs; DEC 11-13; Edinburgh, . 2019. [Poster]

 

Zellnitz, S; Muller, MT; Frohlich, E IMPACT OF BUDESONIDE PARTICLE SHAPE ON UPTAKE BY RESPIRATORY CELLS AND MACROPHAGES
J AEROSOL MED PULM D. 2019; 32(2):A7-A7. [Poster]
Web of Science

 

Fröhlich, E Update Core Facility Imaging, Medical University of Graz
Austrian Biooptics Facilities Meeting; JUL 24, 2018; Vienna, Austria. 2018. [Oral Communication]

 

Fröhlich, E Toxicity testing of nanoparticles in conventional and advanced culture systems
Training School, COST MC1403 Project; APR 2-6, 2018; Valencia, Spain. 2018. [Oral Communication]

 

Mischinger, J;Seles, M; Jesche-Chromecki J;Fröhlich, E;Gutschi T; Salfellner, M;Augustin, H,Pummer, K;Zigeuner, R. Evaluation prognostischer Marker beim Hochrisiko-klarzelligen Nierenzellkarzinom
German Medical Science GMS Publishing House.doi: 10.3205/18urobay050, urn:nbn:de:0183-18urobay0501.. 2018; -44. gemeinsamen Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; June,14-16 2018.; Rosenheim, Germany.. [Oral Communication]
FullText

 

Pinto, JT; Radivojev, S; Fröhlich, E; Paudel, A Insights into DPI sensitivity to humidity and its correlation to formulation physicochemical characteristics: a temporal study using two commercial budesonide products
Drug Delivery to the Lungs; Dec 12-14, 2018; Edinburgh. 2018. [Poster]

 

Radivojev, S; Pinto, JT; Fröhlich, E; Paudel, A Insights into DPI sensitivity to humidity: an integrated in-vitro-in-silico risk-assessment approach
Pharmaceutical Solid State Research Cluster Meeting 2018; SEP 12-14; Leuven, BELGIUM. 2018. [Oral Communication]

 

Radivojev,S; Pinto, JT; Fröhlich, E; Paudel, A Insights into humidity-induced changes on the in-vitro pulmonary deposition and the predicted plasma levels of budesonide from commercial DPIs: a pharmacokinetic model assisted risk assessment approach
Drug Delivery to the Lungs; Dec 12-14, 2018; 2018. [Poster]

 

Sarah Zellnitz, S; Müller, MT; Fröhlich, E Impact of Budesonide Particle Shape on Uptake by Respiratory Cells and Macrophages
Drug Delivery to the Lungs; DEC, 12-14, 2018; Edinburgh. 2018. [Poster]

 

Zellnitz, S; Zellnitz, L; Roblegg, E; Frohlich, E IMPACT OF SALBUTAMOL SULPHATE PARTICLE PROPERTIES ON BIOLOGICAL EFFECTS IN THE LUNG
J AEROSOL MED PULM D. 2018; 31(2):A17-A17.-Drug Delivery to the Lungs; [Poster]
Web of Science

 

Fröhlich, E Genotoxizität -UPDATE
NanoGenoTox Projekttreffen; MAY 3, 2017; Karlsruhe. 2017. [Oral Communication]

 

Fröhlich, E Alternative Methoden an der MUG
3Rs Day; FEB 15, 2018; Graz, Austria. 2017. [Oral Communication]

 

L. Kqiku, M. Roguljic, V. Rajić, K. Hanscho , E. Fröhlich, I. Miletic Biological Features of Bioactive Materials for Root-End Filling
An international multi-disciplinary research meeting hosted by the Continental European & Scandinavian divisions (CED-IADR/NOF) of the International Association for Dental Research (IADR); 21-23.09.2017; Vienna. 2017. [Poster]
FullText

 

Zellnitz, S; Zellnitz, L; Roblegg, E; Fröhlich, E Impact of salbutamol sulphate particle properties on biological effects in the lung
Drug Delivery to the Lungs; DEC, 3-8, 2018; Edinburgh. 2017. [Poster]

 

Fröhlich, E Biological effects of inhaled particles: permeation & toxicity
Inhalation Day @ RCPE; SEPT, 20-21; Graz, Austria. 2016. [Keynote lecture]

 

Fröhlich, E In vitro models for the assessment of short and prolonged exposure to nanoparticles
Topics of Current Hygienic Importance in Nanotoxicology: Theoretical Premises, Hazards Identification and Ways of Their Attenuation; OCT 20-21, 2016; Ekaterinburg, Russia. 2016. [Oral Communication]

 

Fröhlich, E Testung der Nanopartikelwirkungen in physiologisch relevanten in vitro Modellen
9. Sitzung des Plenums der Österreichischen Nanoinformationskommission; JUNE, 21; Vienna, Austria. 2016. [Oral Communication]

 

Fröhlich, E; Meind. C; Leitinger, G; Roblegg, E Toxicological assessment of UCNPs in vitro
Properties, Design and Applications of Upconverting Nanomaterials (UPCON'16); MAY 23-25, 2016; Wroclaw, Poland. 2016. [Poster]

 

Fröhlich E, Meindl C, Leitinger G, Roblegg E Toxicological assessment of UCNPs in vitro
1st Conference and Spring School on Properties, Design and Applications of Upconverting Nanomaterials ; MAY 23-27, 2016; Wrocław, Poland. 2016. [Poster]

 

Fröhlich, EE; Farzi, A; Mayerhofer, R; Reichmann, F; Jačan, A; Wagner, B; Zinser, E; Bordag, N; Magnes, C; Fröhlich, E; Kashofer, K; Gorkiewicz, G; Holzer, P Gut-brain axis in antibiotic-induced gut dysbiosis: focus on metabolites and neuropeptide Y.
Abstracts of the GENIEUR Final Conference. 2016; 21-21.-COST Action BM 1106 GENIEUR Final Conference; MAR 14-15, 2016; Heidelberg, GERMANY. [Oral Communication]

 

Fröhlich, EE; Farzi, A; Mayerhofer, R; Reichmann, F; Jacan, A; Wagner, B; Zinser, E; Bordag, N; Magnes, C; Fröhlich, E; Kashofer, K; Gorkiewicz, G; Holzer, P Antibiotic-induced gut dysbiosis affects cerebral neurotransmitter systems and cognition.
22nd Scientific Symposium of APHAR; SEP 8-10, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

 

Mercuri, A; Wu, S; Zellnitz, S; Salar-Behzadi, S; Bresciani, M; Khinast, J; Frohlich, E UNDERSTANDING THE IN VIVO IMPACT OF CARRIER-DRUG INTER-PARTICLE FORCES VIA ENGINEERED SURFACE MODIFICATIONS: AN IN SILICO INVESTIGATION
J AEROSOL MED PULM D. 2016; 29(3):A5-A5. [Poster]
Web of Science

 

Salar-Behzadi, S; Wu, SQ; Meindl, C; Stranzinger, S; Mercuri, A; Mohr, S; Bresciani, M; Khinast, J; Frohlich, E ADVANCED IN SILICO MODELING OF THE PERFORMANCE OF INHALATION PRODUCTS
J AEROSOL MED PULM D. 2016; 29(3):A19-A19.-DDL26; [Poster]
Web of Science

 

Wu, S; Mercuri, A; Salar-Behzadi, S; Schiaretti, F; Zambelli, E; Brogin, G; Govoni, M; Meindl, C; Stranzinger, S; Mohr, S; Dzidic, N; Bresciani, M; Frohlich, E INFLUENCE OF CALU-3 PERMEABILITY ON IN SILICO PHARMACOKINETIC PREDICTION OF INHALATION PRODUCTS
J AEROSOL MED PULM D. 2016; 29(3):A17-A18.-DDL26; Edinburgh. [Poster]
Web of Science

 

Falk, A; Schimpel, C; Ladenhauf, N; Zechner, P; Jagersbacher-Uhl, S; Roblegg, E; Zimmer, A; Hartl, S; Fröhlich, E; Sinner, F; Katz, G. Scientific Safety Strategy in Nanotechnologies
ChinaNano 2015, International Conference on Nanoscience & Technology ; Sep 3-5, 2015; Peking. 2015. [Oral Communication]

 

Fröhlich, E Toxicity testing in-vitro: principle and specific requirements for the assessment of nanomaterials.
Doctoral College Faculty of Electrical Engineering; APR 21, 2015; Ljubljana, Slovenia . 2015. [Oral Communication]

 

Fröhlich, E Live cell imaging
Cell Culture Days 2015; MAY 7-8; Graz, Austria. 2015. [Oral Communication]

 

Fröhlich, E State of the Art: in-vitro Toxicity testing.
Comparative Medicine Symposium ; MAR 17, 2015; Vienna, Austria. 2015. [Oral Communication]

 

Fröhlich, E; Meindl, C; Mrakovcic, M; Roblegg, E Cellular effects of repeated exposure to nanoparticles
5th Zing Bionanomaterials Conference 2015; APR 25-28, 2015; Carvoeiro, Portugal. 2015. [Oral Communication]

 

Mercuri, A; Sattler, R; Stranzinger, S; Mohr, S; Salar-Behzadi, S; Fröhlich, E Dissolution of Tacrolimus from Modified Release Formulations under Biorelevant Conditions
42nd Annual Meeting & Exposition of the Controlled Release Society; JUL 26-29, 2015; Edinburgh, UK. 2015. [Poster]

 

Roblegg, E; Teubl, BJ, Fröhlich, E Studying the uptake behavior of Nano-TiO2 into the oral cavity
6th International BioNanoMed 2015; APR 8-10, 2015; Graz, Austria. 2015. [Oral Communication]

 

Wu, S; Mercuri, A; Salar-Behzadi, S; Meindl, C; Stranzinger, S; Mohr, S; Dzidic, N; Bresciani, M; Fröhlich, E Influence of in vitro pulmonary permeability on in silico prediction of inhalation products
1st European Conference on Pharmaceutics Drug Delivery; APR 13-14, 2015; Reims, France. 2015. [Poster]

 

Fröhlich, E Testung inhalativer Produkte von in vitro und in vivo Modellen
Cell Culture Days 2014; APR 29+30, 2014; Vienna, Austria. 2014. [Oral Communication]

 

Fröhlich, E.; Meindl, C; Mrakovcic, M; Leitinger, G; Baumgartner, R; Roblegg, E; In-vitro testing for identification of long-term effects of nanoparticles.
6th International Conference on Nanomaterials; NOV 5-7, 2014 ; Brno, Czech Republic. 2014. [Oral Communication]

 

Fröhlich, E; Teubl, B; Schimpel, C; Bauer, B; Meindl, C; Absenger, M; Roblegg, E. Physicochemical requirements for nanoparticle transport across the buccal mucosa
5th International Congress Nanotechnology in Medicine & Biology; MAR 26-28, 2014; Krems, Austria. 2014. [Oral Communication]

 

Gradauer, K; Dünnhaupt, S; Barthelmes, J; Roblegg, E., Fröhlich, E., Leitinger, G; Bernkop-Schnürch, A; Prassl, R Oral peptide delivery by thiomer-coated liposomes
European Symposium on Controlled Drug Delivery; APRIL 16-18, 2014; Egmond aan Zee, Holland. 2014. [Poster]
FullText

 

Gradauer, K; Dünnhaupt, S; Barthelmes, J; Roblegg, E; Fröhlich, E; Leitinger, G; Bernkop-Schnürch, A; Prassl, R Mucoadhesive thiochitosan coated liposomes for oral administration of drugs.
CLINAM-7th Clinical European Conference for Clinical Nanomedicine; JUN 21-25, 2014; Basel, SCHWEIZ. 2014. [Oral Communication]

 

Gradauer, K; Dünnhaupt, S; Barthelmes, J; Roblegg, E; Fröhlich, E; Leitinger, G; Bernkop-Schnürch, A; Prassl, R Oral peptide delivery by thiomer-coated liposomes.
9th World Meeting on Pharmaceutics, Biopharmaceuticsand Pharmaceutical Technology; MÄRZ 31, APRIL 1-4, 2014; Lissabon, PORTUGAL. 2014. [Poster]

 

Hierzerbauer, B; Meindl, C; Roblegg, E; Fröhlich, E Effects of polystyrene particles on a peripheral blood monocytic cell/endothelial cell co-culture system.
10th International Conference and Workshop on Biological Barriers; FEB 16-21, 2014; Saarbrücken, Germany. 2014. [Poster]

 

Meindl, C; Mrakovcic, M; Baumgartner, R; Roblegg, E; Fröhlich, E Chronic cytotoxicity: cellular effects of nanoparticle accumulation
CLINAM-7th Clinical European Conference for Clinical Nanomedicine; JUN 21-25, 2014; Basel, Switzerland. 2014. [Oral Communication]

 

Roblegg, E; Teubl, B; Schimpel, C; Bauer, B; Meindl, C; Absenger, M; Eitzlmayr, A; Fröhlich, E. Thinking Alternatively:Transport of Nanoparticles across the Buccal Mucosa.
10th International Conference and Workshop on Biological Barriers, ; FEB 16-21, 2014; Saarbrücken, Germany,. 2014. [Oral Communication]

 

Schimpel, C; Teubl, B; Absenger, M; Meindl, C; Fröhlich, E; Leitinger, G; Zimmer, A; Roblegg, E. Development of an intestinal permeability model to study transcytosis of polystyrene nanoparticles.
23rd Scientific Congress of the Austrian Pharmaceutical Society; APR 23-25; Graz, Austria. 2014. [Oral Communication]

 

Teubl, B; Leitinger, G; Fröhlich, E; Roblegg, E. Interactions of nano-TiO2 with the buccal mucosa depending on the degree of surface hydrophilicity/hydrophobicity
9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; MAR 31-3, 2014; Lisbon, Portugal. 2014. [Poster]

 

Teubl, B; Leitinger, G; Fröhlich, E; Roblegg, E. Interactions of nano-TiO2 with the buccal mucosa depending on the degree of surface hydrophilicity/hydrophobicity
6th InternationalCongress on Pharmaceutical Engineering; JUN 16-17, 2014; Graz, Austria. 2014. [Poster]

 

Wu, S; Salar-Behzadi, S; Frohlich, E COMPARISON OF IN SILICO AND IN VIVO PHARMACOKINETIC DATA FOR INHALATION PRODUCTS
J AEROSOL MED PULM D. 2014; 27(4):A19-A19. [Poster]
Web of Science

 

Falk, A; Hartl, S; Ladenhauf, N; Roblegg, E; Fröhlich, E; Zimmer, A; Sinner, F. Cooperation enables sustainable commercialization of nanotechnology achievements
Nanosciences&Nanotechnologies NN13; July 9-12, 2013; Thessaloniki, Greece. 2013. [Poster]

 

Falk, A; Hartl, S; Roblegg, E; Fröhlich, E; Zimmer, A; Sinner, F. Thematic Workshop in Toxicology Related Topics *eco- *nano-
Scientific Communication and Cooperation in Europe – Towards a Europeanwide Nano-Community; June 14-15, 2013; Sungreen University of Nova Gorica, Slovenia. 2013. [Oral Communication]

 

Falk, A; Hartl, S; Roblegg, E; Fröhlich, E; Zimmer, A; Sinner, F. BioNanotechnology – from Thematic Research to Innovation
EuroNanoForum + NanoTech Europe 2013; June 18-20, 2013; Dublin, Ireland. 2013. [Oral Communication]

 

Fröhlich, E. Effects of Nanoparticles in endothelial cells: whole genome expression analysis
Affymetrix Seminar; JUL 3, 2013; Graz, Austria. 2013. [Oral Communication]

 

Fröhlich, E. Toxicity of nanoparticles
International student Congress; JUL 4.-5, 2013; Graz, Austria. 2013. [Oral Communication]

 

Fröhlich, E. ZMF Core-Facility Microscopy
BioImaging Graz Meeting; JUN 28, 2013; Graz, Austria. 2013. [Oral Communication]

 

Fröhlich, E. Scientific Applications to Ensure Safe Implementation of Nanoparticles
NanoForce Infoday; JUN 5, 2013; Vienna, Austria. 2013. [Oral Communication]

 

Fuchs, R; Schittmayer, M; Stracke, A; Allard, N; Zeller, C; Rehnolt, C; Schwach, G; Raninger, AM; Rinner, B; Kueznik, T; Absenger, M; Froehlich, E; Birner-Gruenberger, R; Leitinger, G; Ghaffari Tabrizi-Wizsy, N; Pfragner, R; Sadjak, A. Identifizierung Quinazolin sensitiver Proteine in humanen Krebszellen
Cell Culture Days; APR 25-26, 2013; Graz, AUSTRIA. 2013. [Oral Communication]

 

Mrakovcic M, Meindl C, Neudecker M, Leitinger G, Roblegg E, Ferk F, Knasmüller S, Falk A, Fröhlich E. Diameter and surface functionalization of short carbon nanotubes influence their genotoxic effects.
CLINAM-6th Clinical European Conference for Clinical Nanomedicine; 23.-26.6.2013; Basel, Switzerland. 2013. [Poster]

 

Mrakovcic, M; Neudecker, M, Ferk, F; Knasmüller, S; Roblegg, E; Fröhlich, E. Plain and carboxylated short carbon nanotubes may cause genotoxic effects by different mechanisms
BioNanoMed 4th International Congress Nanotechnology in Medicine & Biology; MAR 13.-15., 2013; Krems, Austria. 2013. [Oral Communication]

 

Nikitina, L.; Juch, H.; Dohr, G.; Falk, A.; Froehlich, E. Screening for reproductive toxicity of nanoparticles
The European Summit for Clinical Nanomedicine and Targeted Medicine; JUN 24-26; Basel, Schweiz. 2013. [Oral Communication]

 

Roblegg E, Teubl BJ, Leitinger G, Schneider M, Lehr CM, Zimmer A, Fröhlich E. Transport studies of nano-TiO2 particles into/across the buccal mucosa.
AAPS Annual Meeting and Exposition; 10.-14.10.2013; San Antonio, USA. 2013. [Poster]

 

Schimpel C, Teubl B, Leitinger G, Fröhlich E, Zimmer A, Roblegg E. Development of an intestinal 3D in vitro permeability model to study the transport of polystyrene nanoparticles.
AAPS Annual Meeting and Exposition; 10.-14.10.2013; San Antonio, USA. 2013. [Poster]

 

Schrank S, Bauer B, Meindl C, Absenger M, Fröhlich E, Roblegg E. Impact of â-Estradiol on Disintegration, Mucoadhesion and Permeabiltity of Micropellets for Buccal Application.
AAPS Annual Meeting and Exposition; 10.-14.10.2013; San Antonio, USA. 2013. [Poster]

 

Teubl, BJ; Leitinger, G; Fröhlich, E; Schneider, M; Lehr, CM; Zimmer, A; Roblegg, E. Investigations of the Oral Uptake of Titanium Dioxide Nanoparticles via the Buccal Mucosa.
AIChE Annual Meeting; NOV 3-8, 2013; San Francisco, USA. 2013. [Oral Communication]

 

Wu, S; Salar-Behzadi, S; Fröhlich, E. Comparison of in silic and in vivo pharmakinetic data for inhalation products.
Drug Delivery to the Lungs 24; 11.11.-13.11. 2013; Edinburgh, United Kingdom. 2013. [Poster]

 

Falk, A; Hartl, S; Roblegg, E; Zimmer, A; Fröhlich E; Sinner, F European Centre for Nanotoxicology – Austrian Example of a European Hub in Nanotoxicology.
keine. 2012; -4th NanoImpactNet Integrating Conference and the 1st QNano Integrating Conference; February 27-29, 2012; Dublin, Ireland. [Poster]

 

Falk, A; Hartl, S; Roblegg, E; Zimmer, A; Fröhlich E; Sinner, F European Centre for Nanotoxicology – Austrian Example of a European Hub in Nanotoxicology
4th NanoImpactNet Integrating Conference and the 1st QNano Integrating Conference; February 27-29, 2012; Dublin, Ireland. 2012. [Poster]

 

Falk, A; Hartl, S; Roblegg, E; Zimmer, A; Fröhlich E; Sinner, F. Scientific Expert Committee in Nanotoxicology.
keine. 2012; -European Summit for Clinical Nanomedicine, CLINAM; May 7-9, 2012; Basel, Switzerland. [Poster]

 

Falk, A; Hartl, S; Roblegg, E; Zimmer, A; Fröhlich E; Sinner, F. Scientific Expert Committee in Nanotoxicology
European Summit for Clinical Nanomedicine, CLINAM; May 7-9, 2012; Basel, Switzerland. 2012. [Poster]

 

Falk, A; Hartl, S; Roblegg, E; Zimmer, A; Fröhlich E; Sinner, F. European Center for Nanotoxicology – österreichische Anlaufstelle zur Nanotoxikologie
Werkstoffkongress; March 28, 2012; Leoben, Austria. 2012. [Oral Communication]

 

Falk, A; Hartl, S; Roblegg, E; Zimmer, A; Fröhlich E; Sinner, F. EURO-NanoTox – European Center for Nanotoxicology, Safe implementation of nanotechnologies: Common challenges
NanoSafetyCluster-Workshop at Minatec; May 29-31, 2012; Grenoble, France. 2012. [Oral Communication]

 

Falk, A; Roblegg, E; Zimmer, A; Hartl, S; Fröhlich, E; Sinner, F. Concerns in Nanosafety – Establishment of an International Scientific Expert Committee
Nanosciences&Nanotechnologies NN12; July 3-6, 2012; Thessaloniki, Greece. 2012. [Oral Communication]

 

Fröhlich, E Nanotoxikologische Untersuchungsmethoden,
NanoForce Infoday; Oct 17; Graz, Austria. 2012. [Oral Communication]

 

Fröhlich, E Nutzen von in-vitro Untersuchungen zur toxikologischen Einschätzung von Nanopartikeln
41. Steirische Fortbildungstagung der Biomedizinischen AnalytikerInnen; Oct, 5; Graz, Austria. 2012. [Oral Communication]

 

Fröhlich, E; Meindl, C; Mrakovcic, M. In-vitro models for the detection of long-term nanoparticle effects
Workshop on Nanomaterial Safety: Biomarkers ; Feb, 26-29; St. Christoph/Arlberg, Austria. 2012. [Oral Communication]

 

Fröhlich, E, Roblegg, E Lessons learned in the toxicity testing of nanoparticles
9th International Conference on Nanosciences & Nanotechnologies; July, 3-6; Thessaloniki, Greece. 2012. [Oral Communication]

 

Fröhlich LF, Mrakovcic M, Smole C, Chowdhury P, Fröhlich E, Zatloukal K TP53 mutational status determines uterine tumor cell response towards histone deacetylase inhibitor induced apoptosis or autophagy
4th Annual Meeting of the Austrian Association of Molecular Life Sciences and Biotechnology; SEP 17-19, 2012; Graz, AUSTRIA. 2012. [Oral Communication]

 

Fröhlich LF, Mrakovcic M, Smole C, Chowdhury P, Fröhlich E, Zatloukal K TP53 mutational status determines uterine tumor cell response towards histone deacetylase inhibitor induced apoptosis or autophagy
4th Annual Meeting of the Austrian Association of Molecular Life Sciences and Biotechnology; SEP 17-19; Graz, Austria. 2012. [Poster]

 

Fröhlich, LF; Mrakovcic, M; Smole, C; Lahiri, P; Fröhlich, E; Zatloukal, K P53 determines histone deacetylase inhibitor induced cytotoxic tumor cell response
ZMF Days 2012; NOV 8, 2012; Graz, Austria. 2012. [Oral Communication]

 

Fuchs, R; Schwach, G; Rinner, B; Kueznik, T; Absenger, M; Froehlich, E; Stracke, A; Birner-Gruenberger, R; Sadjak, A; Pfragner, R Quinazoline sensitive binding sites are promising new targets for chemotherapy of neuroendocrine tumors.
13th International Workshop on Multiple Endocrine Neoplasia; SEPT 5-8, 2012; Liege, BELGIUM. 2012. [Oral Communication]

 

Fuchs, R; Schwach, G; Rinner, B; Stracke, A; Allard, N; Kueznik, T; Froehlich, E; Ruth Birner-Gruenberger, R; Sadjak, A; Pfragner, R Prazosin induces apoptosis in Medullary Thyroid Cancer cells by targeting multiple organelles.
European Thyroid Journal; 36 Annual Meeting of the European Thyroid Association, Programme and Abstracts. 2012; 1(S1):1-208.-36th Annual Meeting of the ETA; SEPT 8-12, 2012; Pisa, ITALY. (ISBN: 978-3-318-0222 ) [Poster]

 

Fuchs, R; Schwach, G; Rinner, B; Stracke, A; Allard, N; Zeller, C; Pfragner, R; Ghaffari Tabrizi-Wizsy, N; Froehlich, E; Kueznik, T; Absenger, M; Birner-Gruenberger, R; Leitinger, G; Sadjak, A Identification of Quinazoline sensitive binding sites in human cancer cells
4th ÖGMBT ANNUAL MEETING; SEPT 17-19, 2012; Graz, AUSTRIA. 2012. [Poster]

 

Gradauer, K; Vonach, C; Dünnhaupt, S; Barthelmes,J; Roblegg, E; Fröhlich, E; Bernkop-Schnürch, A; Prassl, R Thiochitosan-coated liposomes as oral delivery systems for peptide drugs
AAPS (American Association of Pharmaceutical Scientists) 2012 Annual Meeting and Exposition; Okt 14-18, 2012; Chicago, USA. 2012. [Poster]

 

Mrakovcic, M; Absenger, M; Meindl, C; Fröhlich, E Evaluation of Long-term Cytotoxicity of Nanomaterials on Endothelial Cells in a 3D Cell Culture
BioNanoMed 2012; MAR 1-2, 2012; Krems a. d. Donau, AUSTRIA. 2012. [Poster]

 

Mrakovcic, M; Absenger, M; Meindl, C; Riedl, R; Roblegg, E; Fröhlich, E Assessing Long-term Effects of Nanomaterials on Endothelial Cells in a 3D Cell Culture System
9th International Conference on Nanosciences and Nanotechnology; JUL 3-6,2012; Thessaloniki, GREECE. 2012. [Oral Communication]

 

Prietl, B; Meindl, C; Roblegg, E; Pieber, TR; Lanzer, G; Fröhlich, E Nanopartikel – immunologische Effekte
45. Jahreskongress der deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie, Graz; Sept, 11-14; Graz, Austria. 2012. [Oral Communication]

 

Roblegg, E; Teubl, B; Leitinger, G; Zimmer, A; Fröhlich, E Development of an advanced buccal in-vitro model
8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology+; Mar 18-22; Istanbul, Turkey. 2012. [Oral Communication]

 

Roblegg, E; Teubl, BJ; Meindl, C; Zimmer, A; Fröhlich, E Ex-VivoTransport Studies of Polystyrene Nanoparticles into the Buccal Mucosa: Impact of Size, Surface Charge and Hydrophobicity/Hydrophilicity on the Penetration Behavior
9th International Conference and Workshop on Biological Barriers –in vitro and in silico Tools for Drug Delivery and Nanosafety Research; Feb, 29-Mar, 9; Saarbrücken, Germany. 2012. [Oral Communication]

 

Teubl, B; Fröhlich, E; Meindl, C; Zimmer, A; Roblegg, E. Penetration Studies of Polystyrene Nanoparticles into the Buccal Mucosa: Influence of Size, Surface Charge and Hydrophobicity/Hydrophilicity
BioNanoMed 2012, 3rd International Congress Nanotechnology in Medicine & Biology; Mar 1-2; Krems, Austria. 2012. [Oral Communication]

 

Traunmüller, E; Maurer-Ertl, W; Kürzl, G; Fröhlich, E; Ghaffari-Tabrizi, F; Bodo, K; Liegl-Atzwanger, B; Leithner, A Schmerzanalyse bei Kindern mit Fibröser Dysplasie.
Abstractbook der 3. Jahrestagung der Österreichischen Gesellschaft für Tumororthopädie. 2012; 26--3. Jahrestagung der Österreichischen Gesellschaft für Tumororthopädie; APR 20-21, 2012; Graz, AUSTRIA. [Oral Communication]

 

Falk, A; Roblegg, E; Zimmer, A; Fröhlich, E; Sinner, F. EURO-NanoTox: An Austrian Example of a European Hub in Nanotoxicology
University Village, Conference on Clinical Nanomedicine CLINAM; May 22-25, 2011; Basel, Switzerland. 2011. [Oral Communication]

 

Falk, A; Roblegg, E; Zimmer, A; Fröhlich, E; Sinner, F. EURO-NanoTox: An Austrian Example of a European Hub in Nanotoxicology
Workshop “Advances in Measurement of Nanomaterials and their Impact on Man and the Environment”; September 14, 2011; Begbroke Science Park, Oxford University, United Kingdom. 2011. [Oral Communication]

 

Fröhlich, E Advantages and problems of nanoparticles in medicine.
Nanoinitiative Project Cluster NILaustria Consortium Meeting; Nov 3-4, 2011; Linz, Austria. 2011. [Oral Communication]

 

Gradauer, K; Judmaier, C; Leitinger, G; Fröhlich, E; Roblegg, E; Bernkop-Schnürch, A; Prassl, R Thiomer coated Liposomes: Development of a mucoadhesive drug delivery system
Liposomes in Jerusalem; May 15-19, 2011; Jerusalem, Israel. 2011. [Poster]

 

Mrakovcic, M; Absenger, M; Riedl R; Pieber TR; Fröhlich E Assessment of Long-term Cellular Effects of Nanoparticles on Endothelial Cells in a 3D Cell Culture System
Doctoral Day 2011; NOV 4, 2011; Graz, AUSTRIA. 2011. [Poster]

 

Roblegg, E; Leitinger, G; Letofsky-Papst, I; Fröhlich, E In vitro Permeability studies of NMs across the Buccal Mucosa: Influence of Size and Surface Charge
2nd Expert Consultation Meeting of the WPMN Steering Group 7 on Alternative Test Methods; JAN 18-20, 2011; Paris, France. 2011. [Oral Communication]

 

Roblegg, E; Schrank, S; Lesky, L; Fröhlich, E Buccal Investigations of Immediate Release Micro-Pellets Based on Ludiflash®
PharmSciFair - Pharmaceutical Sciences Fair and Exhibition; June 13-17, 2011; Prague, Czechia. 2011. [Poster]

 

Teubl, B; Fröhlich, E; Zimmer, A; Roblegg, E Transport Studies of Polystyrene Nanoparticles across the Buccal Mucosa
PharmSciFair - Pharmaceutical Sciences Fair and Exhibition; June, 13-17, 2011; Prague, Czechia. 2011. [Poster]

 

Teubl, B; Leitinger, G; Fröhlich, E; Roblegg, E Development of an Alternative Buccal In-Vitro Model to study Cellular Interactions of Nanomaterials
ICPE 2011; Book of Abstracts. 2011; 39--ICPE-5th International Congress on Pharmaceutical Engineering ; SEP 29-30; Graz, AUSTRIA. [Oral Communication]
FullText

 

Falk, A; Hartl, S; Roblegg, E; Zimmer, A; Fröhlich E; Sinner, F. Nanoscale Material: A new challenge for toxicology.
FramingNano; March 24, 2010; Frankfurt, Germany. 2010. [Oral Communication]

 

Falk, A; Roblegg, E; Fröhlich, E; Zimmer, A; Sinner, F. Key Activities: Austrian Research Hub, EURO-NanoTox
Nanosciences&Nanotechnology - NN10; July 10, 2010; Ouranopoli, Greece. 2010. [Oral Communication]

 

Falk, A; Roblegg, E; Fröhlich, E; Zimmer, A; Sinner, F. Key Activities: Austrian Research Hub, EURO-NanoTox
Nanosciences&Nanotechnology - NN10; July 10, 2010; Ouranopoli, Greece. 2010. [Oral Communication]

 

Falk, A; Roblegg, E; Zimmer, A; Fröhlich, E; Sinner, F European Center for Nanotoxicology: the Austrian Hub for Nanotoxicology.
FramingNano-Workshop; MAR 24, 2010; Frankfurt, Germany. 2010. [Oral Communication]

 

Fröhlich, E; Fink, I; Wahl, R Differences in efficacy and mode of action of differentiating substances in thyroid carcinoma cells
14th International Thyroid Congress; Sept, 11-14, 2010; Paris. 2010. [Poster]

 

Johannes Mischinger, Eleonore Fröhlich, Antonia Griesbacher, Karl Pummer, Sebastian Mannweiler, Richard Zigeuner, Katja Lipsky Prognostic relevance of B7H1 and B7H3 protein expressions in metastatic clear cell renal cell carcinoma.
http://dx.doi.org/10.1200/jco.2010.28.15_suppl.e15074. 2010; -ASCO 2010 Annual Meeting; JUNE 04.-08., 2010; Chicago, USA.

 

Lipsky, K; Mischinger, J; Zigeuner, R; Griesbacher, A; Pummer, K; Mannweiler, S; Fröhlich, E Einfluss co-inhibitorischer Moleküle auf das Überleben von Patienten mit metastasiertem Nierenzellkarzinom
30. Internationale Urologische Woche Kitzbühel; Jän. 24-30, 2010; Kitzbühel, Austria. 2010. [Oral Communication]

 

Mrakovcic, M; Absenger, M; Meindl, C; Mujk, D; Fröhlich, E Evaluation of Cell Culture Models for the Assessment of Chronic Cytotoxic Effects of Nanoparticles
Joint ZMF and Docotral Days; NOV 5-6, 2010; Graz, AUSTRIA. 2010. [Poster]

 

Prietl, B; Meindl, C; Höller, E; Absenger, M; Pieber, TR; Fröhlich, E Size matters: Nanoparticles affect immune cells and endothelial cells
Conference Proceedings of the 3rd European Conference for Clinical Nanomedicine2010; -3rd European Conference for Clinical Nanomedicine; MAY 10-12, 2010; Basel, SWITZERLAND. [Poster]

 

Roblegg, E; Blass, S; Rabensteiner, DF; Trummer, G; Schmut, O Zytotoxizitäts- und Permeabilitätsstudien zur Untersuchung der Aufnahme von nanostrukturierten Materialien über das Auge
Spektrum der Augenheilkunde2010; 24(2):135-136.-51. Tagung der Österreichischen Ophthalmologischen Gesellschaft; MAY 13-15, 2010; Zell am See, AUSTRIA. [Poster]

 

Roblegg, E; Falk, A; Fröhlich, E; Zimmer, A; Sinner, F In vitro studies of NM transport across the buccal mucosa -The European Center for Nanotoxicology.
Expert consultation meeting of the WPMN SC7 on Alternative Test Methods; APR 28-30, 2010; Paris, France. 2010. [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Kratky, D; Froehlich, E; Strunk D Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis favors MAPK p38-dependent foam cell formation.
24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2010; 42(237):13-13.-Austrotransplant; OCT 27-29, 2010; Villach, AUSTRIA. [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Kratky, D; Fröhlich E; Strunk, D Pro-Angiogenic Induction of Myeloid Cells for Therapeutic Angiogenesis Can Favor MAPK p38-dependent Foam Cell Formation.
52nd annual meeting2010; 116(21):1836-1836.-Annual Society of Hematology; DEC 4-7, 2010; Orlando, USA.

 

Scheipl, S; Froehlich, EV; Leithner, A; Beham, A; Quehenberger, F; Mokry, M; Stammberger, H; Varga, P; Windhager, R; Liegl-Atzwanger, B Targeted therapies for chordomas: does IGF-1E signaling provide new treatment options?
Abstract book of the 23rd EMSOS Meeting 2010;2010; 119-120.-23rd EMSOS Meeting; MAY 5-7, 2010; Birmingham, UNITED KINGDOM. [Poster]

 

Sinner, F; Roblegg, E; Fröhlich, E; Zimmer, A; Falk, A. European Center for Nanotoxicology –Nanoscale Materials: A New Challenge for Toxicology
Sci Pharm. 2010; 78:580. 2010; -8th Central European Symposium on Pharmaceutical Technology (CESPT), Satellite Symposium: 4th International Graz Congress on Pharmaceutical Engineering; September 16th–18th, 2010; Graz, Austria. [Oral Communication]

 

Sinner; F; Roblegg, E; Fröhlich, E; Zimmer, A; Falk, A. European Center for Nanotoxicology –Nanoscale Materials: A New Challenge for Toxicology
Sci Pharm. 2010. 2010; 78(580):-8th Central European Symposium on Pharmaceutical Technology (CESPT), Satellite Symposium: 4th International Graz Congress on Pharmaceutical Engineering; September 16th–18th; Graz, Austria, . [Oral Communication]

 

Wolf, P; Gruber-Wackernagel, A; Legat, F; Hofer, A; Bambach, I; Mayer, G; Absenger, M; Frohlich, E; Byrne, S Successful phototherapy of polymorphic light eruption patients is associated with a recruitment of mast cells into the skin
J INVEST DERMATOL. 2010; 130: S48-S48. [Oral Communication]
Web of Science

 

Falk, A; Hartl, S; Roblegg, E; Zimmer, A; Fröhlich E; Sinner, F. The European Center of Nanotoxicology – An Austrian Activity
NanoTech2009 Conference; October 26-28, 2009; KLCC, Kuala Lumpur, Malaysia. 2009. [Oral Communication]

 

Fröhlich, E; Mayer, E; Wahl, R Dipeptidyl peptidase IV as marker in the screening for differentiating agents in transformed thyrocytes.
Acta med Port. 2009; 22: 82--34th Annual Meeting of the European Thyroid Association; 5.- 9. 9.2009; Lisbon,Portugal. [Poster]

 

Fröhlich, E; Mayer, E; Wahl, R Dipeptidyl peptidase IV as marker in the screening for differentiating agents in transformed thyrocytes.
52nd Symposium of the German Endocrine Society abstract book. 2009; -52nd Symposium of the German Endocrine Society; 4.-7.3.2009; Giessen, Germany. [Poster]

 

Fröhlich, E; Roblegg, E; Sinner, F Health Effects of Nanomaterials – the European Center of Nanotoxicology.
3rd International Conference on Nano-Technology; 18.3.-20.3.2009; Vienna, Austria. 2009. [Oral Communication]

 

Prietl, B; Samberger, C; Kueznik, T; Lanzer, G; Pieber, TR; Fröhlich, E Size-dependent effects of nanoparticles on different populations of leukocytes
EuroNanoMedicine 2009 Konferenzband2009; -EuroNanoMedicine 2009; 28.-30.9.2009; Bled, Slovenia. [Oral Communication]

 

Prietl, B; Samberger, C; Kueznik, T; Pieber, T; Fröhlich, E Size-dependent effects of nanoparticles on immune cells and endothelial cells
51st Symbosium of the Society for Histochemistry2009; -Nanostructures; OCT 7-10, 2009; Mieders, AUSTRIA. [Poster]

 

Roblegg, E; Fröhlich, E; Samberger, C; Zaversky, M; Zimmer, A Buccal permeability studies of nanostructured materials
4th International Conference Environmental Effects of Nanoparticles and Nanomaterials Abstract book. 2009; -4th International Conference Environmental Effects of Nanoparticles and Nanomaterials.; 6.-9.9.2009; Vienna, Austria. [Poster]

 

Roblegg, E; Fröhlich, E; Samberger, C; Zaversky, M; Zimmer, A Buccal permeability studies of nanostructured materials.
International Graz Congress for Pharmaceutical Engeneering; 17.-18.9.2009; Graz, Austria. 2009. [Oral Communication]

 

Roblegg, E; Fröhlich, E; Sinner, F European Center for Nanotoxicology: the Austrian Hub for Nanotoxicology.
BioNanoMed, International Congress in Nanotechnology in Medicine & Biology; JAN 26-27, 2009; Krems, Austria. 2009. [Oral Communication]

 

Rohde, E; Pfeifer, T; Schallmoser, K; Reinisch, A; Hofmann, NA; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D Pro-atherogenic risk of cellular therapy for vascular regeneration?
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S203-S204.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN. [Poster]
Web of Science

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D CELLULAR THERAPEUTIC ANGIOGENESIS: IN VITRO FOAM CELL DEVELOPMENT OF MONOCYTES BUT NOT MESENCHYMAL STROMAL CELLS.
3rd International Workshop on Multipotent Stromal Cells (MSCs) for Regenerative Medicine and Immune Regulation; JUN 12-13, 2009; Frankfurt am Main, GERMANY. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D In vitro Foam Cell Development of Bone Marrow-Derived Cells: Implications for Therapeutic Angiogenesis?
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie2009; 32(4):215-216.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 ) [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Increased Foam Cell Potential of Human Blood and Marrow-Derived Cells after Pro-Angiogenic Induction as an Apparent Risk Factor of Therapeutic Angiogenesis.
42nd Annual Meeting of the German Society for Transfusion Medicine and Immunohematology2009; 26(S1):45-45.-German Society for Transfusion Medicine and Immunohematology (DGTI); SEP 15-18, 2009; Rostock, GERMANY. (ISBN: 978-3-8055-9325-0 ) [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk D Foam Cell Development of human Blood and Marrow-Derived Cells as a Risk Factor of Therapeutic Angiogenesis?
ZMF-Doctoral Day; NOV 5-6, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk D Safety of stem cell transplantation to treat cardiovascular diseases: foam cell formation of human blood and marrow-derived cells as a risk factor of therapeutic angiogenesis?
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2009; 41(231):10-11.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 21-23, 2009; Seefeld, AUSTRIA. [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA.; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Elevated Foam Cell Formation After Pro-Angiogenic Inductions of Human Blood and Marrow-Derived Cells as an Apparent Risk Factor of Therapeutic Angiogenesis.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Atherogenesis as a risk factor accompanying cellular therapeutic angiogenisis?
2009 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology2009; 2(2):19-20.-ÖGHO Frühjahrestagung; APR 16-18, 2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 ) [Poster]

 

Fröhlich, E Nanotoxikologie in Österreich
Karlsruhe Research Center; Sep 1, 2008; Karlsruhe, Germany. 2008. [Oral Communication]

 

Fröhlich, E Toxikologie von Nanopartikeln
Universitätstag Alpbach; Aug 23-24, 2007; Alpbach, Austria. 2008. [Oral Communication]

 

Fröhlich, E; Czarnocka, B; Brossart, P; Wahl, R Arsenic trioxide has multiple cellular targets in thyroid cancer cell lines
Horm. Res. 2008; 69(S3):2--33rd Annual Meeting of the European Thyroid Association ; 20.-24.9, 2008; Thessaloniki-Chalkidiki. [Poster]

 

Fröhlich, E; Fink, I; Wahl, R Espression and inhibition of transketolase like 1 in thyroid carcinoma cell lines.
Clin. Chem. Lab. Med2008; 46: A156--5th Annual Conference German United Society of Clinical Chemistry and Laboratory Medicine; 21.-24.9, 2008; Mannheim, Germany. [Poster]

 

Lohberger, B; Stadelmeyer, E; Payer, M; Bartmann, C; Strunk, D; DeVaney, T; Froehlich, E; Jakse, N; Windhager, R; 3D Migration and Differentiation Analysis of Intraoral Harvested MSC at Different Bone Substitutes.
ZMF.DAY ; NOV 12, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Mayer, A; Muhry, N; Novak, A; Frohlich, E Influence of size and surface charge on the hemocompatibility of polystyrene particles
TOXICOL LETT. 2008; 180: S223-S224.-45th Congress of the European-Societies-of-Toxicology; OCT 05-08, 2008; Rhodes, GREECE. Doi: 10.1016/j.toxlet.2008.06.100 [Poster]
Web of Science FullText FullText_MUG

 

Mayer, A; Rinner, B; Reinisch, A; Strohmaier, H; Fröhlich, E Flow Cytometric assessment of pro-coagulating and inflammatory action of nanoparticles
XXIV International Congress – International Society for Analytical Cytology (ISAC)2008; A144 P42: 149--XXIV International Congress – International Society for Analytical Cytology (ISAC); MAY 17-21, 2008; Budapest, HUNGARY. [Poster]

 

Rohde, E; Aflaki, E; Froehlich, E; Lanzer, G; Kratky, D; Strunk, D Combating Cardiovascular Disease: Is there a Risk of Foam Cell Formation in Transplanted Angiocompetent Cells Compromising Intended Beneficial Effects of Vascular Regenerative Therapy?
Fiftieth annual meeting abstracts2008; 112(11):665-666.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA. [Oral Communication]
Web of Science

 

Fröhlich, E; Samberger, C; Kueznik, T; Absenger, A; Roblegg, E; Zimmer, A; Griesbacher, M; Pieber, T Evaluation of cytotoxicity tests for the identification and characterization of nanoparticle toxicity
ZMF Day; Nov, 22, 2007; Graz, Austria. 2007. [Poster]

 

Fröhlich, E; Samberger, C; Kueznik, T; Absenger, A; Roblegg, E; Zimmer, A; Griesbacher, M; Pieber, T Critical factors in the assessment of cytotoxicity of nanoparticles by standard assays
International Conference on Nanomedicine; Sep 9-11, 2007; Chalkidiki, Greece. 2007. [Poster]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum